We previously demonstrated that after a severe cryoinjury to the right ventricle of the heart, adult MRL mice display structural and functional recovery with myocardial tissue replacement resembling that seen in amphibians. The control non-regenerating adult C57BL/6 (B6) mouse shows a predominant scar response. In the present study, radiation chimeras reconstituted with fetal liver cells from either healer MRL or nonhealer B6 mice were generated to test for a transfer of phenotype. Allogeneic MRL fetal liver cells were injected into x-irradiated (9 Gy) B6 mice and B6 fetal liver cells were injected into x-irradiated MRL mice. In these allogeneic chimeras, the healing response to cardiac cryoinjury was predominantly of the donor phenotype. Thus, MRL fetal liver cells transferred the healing phenotype to the B6 nonhealer with the appearance of Y-chromosome positive, donor-derived cardiomyocytes in the injury site and MRL-like healing with little scar. Similarly, B6 fetal liver cells transferred the nonhealing phenotype to the MRL with little cardiomyocyte growth and an acellular B6-like scar. These results are in contrast to the ear hole closure response which was of the recipient phenotype. We conclude that, in the case of the heart, fetal liver-derived stem cells regulate regenerative healing.
INTRODUCTION W
OUND HEALING of mammalian tissue is an essential process in the maintenance of body integrity. The general mechanism of wound healing usually studied in adult mammals is repair, ie scarring. in contrast to regeneration seen in more primitive vertebrates (Clark, 1996; Gross, 1996; Stocum, 1996) . There are, however, mammalian tissues that can regenerate such as adult mammalian skeletal muscle which recruits a population of mitotically active satellite cells that contribute to the resultant stable population of myonuclei (Mauro, 1961; Schultz, 1976; Armand et al., 1983; Bischoff, 1994 : Koishi et al., 1995 Seale and Rudnicki, 2000) .
It is a widely held belief that mammalian myocardium does not contain reserve cells, that terminally differentiated adult cardiomyocytes generally do not proliferate, and therefore that the heart does not regenerate (Nadal-Ginard, 1978; Soonpa and Field, 1998; Taylor et al., 2002) . Recent observations, however, suggest otherwise. To a limited degree, it has been shown that adult cardiomyocyte proliferation seems to occur (Carbone et al., 1995; Beltrami et al., 2001; Anversa and Kastura, 1998) . This has been shown in animal models where marked chimeric bone marrow cells have been shown to contribute to the cardiomyocyte population in the heart (Ferrari et al., 1998; Jiang et al., 2000; Goodell et al., 2001; Jackson et al., 2001; Orlic et al., 2001a,b; Toma et The Wistar Institute, Philadelphia, Pennsylvania. al., 2002) . This has also been shown in humans where female heart transplants in male recipients display Y chromosome-positive cardiomyocytes (Laflamme et al., 2002; Quaini et al., 2002) . Resident stem cell populations present in the adult heart (Warejcki et al., 1996; Urbanek et al., 2003; Beltrami et al., 2003; Oh et al., 2003; Martin et al., 2004) are another potential source of new and proliferating cardiomyocytes. The issue of the presence of new and dividing cells and the source of those dividing cells in the adult heart, however, is still controversial.
How stem cells contribute to a new cardiomyocyte population is not entirely clear. An obvious possibility is the direct transdifferentiation of stem cells into mature cardiomyocytes. However, there is recent evidence that stem cells fuse with and assume the phenotypic characteristics of a variety of cell types rather than transdifferentiate (Bjornson et al., 1999; Pittenger et al., 1999; Terada et al., 2002; Clarke et al., 2000) . This has been shown for cardiomyocytes as well (Klug et al., 1996; Murry et al., 2004; Shi et al., 2004) . Whether there are different populations of stem cells responsible for fusion or transdifferentiation is an issue that remains to be determined (Balsam et al., 2004) .
Our laboratory discovered that the MRL mouse strain has a unique capacity for wound healing and regeneration as shown by the closure of ear hole punches with normal tissue architecture and cartilage replacement reminiscent of amphibian regeneration as opposed to mammalian scarring Heber-Katz et al., 2004a) . The control C57BL/6 (B6) mouse, like most every other mouse strain, does not close ear holes but rather forms a circumferential scar. Many of the genetic loci have been identified and it is clear that this is a complex multigenic and sexually dimorphic trait (McBrearty et al., 1998; Masinde et al., 2001; Blankenhorn et al., 2003; Heber-Katz et al., 2004b) . Furthermore, this mouse has also been shown to regenerate injured heart tissue in contrast to the B6 mouse which forms an acellular scar (Leferovich et al., 2001) .
We made use of the identification of healer and nonhealer strains to test whether mixed chimeric mice would demonstrate a change in phenotype. Previous studies using 10-50 million adult bone marrow cells transferred into lethally x-irradiated adult recipients indicated that a conversion of neither ear hole closure (Kench et al., 1999 , HeberKatz et al., 2004c Leferovich, in preparation) nor heart healing phenotypes (Heber-Katz et al., 2004c; Leferovich, in preparation) was seen 30 days later. In the present study, we tested fetal liver chimeras using the MRL/MpJ and B6 mouse strains for both ear hole closure and heart injury studies. Though conversion was again not seen in the case of ear hole closure after 30 days, conversion was demonstrated for heart injury in the same time period, and in both directions. Thus, nonhealing recipients were made cardiac healers and healer recipients were made cardiac nonhealers. This was determined from the degree of scar formation, fibrosis, and the appearance of islands of maturing cardiomyocytes, many of them of donor origin as shown by Y chromosome in situ hybridization.
MATERIALS AND METHODS

Animals
The MRL/MpJ mice were obtained from the Jackson Laboratories (Bar Harbor, ME) and C57BL/6 (B6) were obtained from Taconic Laboratories (Germantown, NY). Animals were maintained under standard conditions at the Association of Assessment and Accreditation of Laboratory Animal Care International (AALAC)-approved Wistar Institute Animal Facility (Philadelphia, PA). The ear hole injury and cardiac cryoinjury protocols have been approved by the Wistar Institute Institutional Animal Care and Use Committee (IACUC).
Chimera production
Adult female mice (3-6 months old) were maintained on antibiotic water (polymyxin B 0.6 mg/mL and neomycin 250 mg/mL) for two days prior to being lethally irradiated with a dose of 900 rads (9 Gy) from a Cs-137 source. Fetal liver cells were used as a source of stem cells that was free of immunocompetent T cell populations. Fetal liver cells were obtained from embryonic day 16-18 fetuses and 8-10 livers were pooled. Single cell suspensions were injected intravenously. Specifically, MRL/MpJ fetal liver cells (2 ϫ 10 7 cells/recipient) were injected into irradiated B6 mice (n ϭ 4) in the first experiment of which three mice were used for analysis and B6 fetal liver cells (2 ϫ 10 6 cells/recipient) were injected into irradiated MRL/MpJ mice (n ϭ 7) of which four mice were used for analysis. Antibiotic water therapy was maintained for one month post-irradiation. At sacrifice, splenocytes were analyzed for chimerism using FACS to detect cells labeled with FITC-anti mouse H-2Kk and PE-anti mouse H2Kb (BD Pharmingen, San Diego, CA).
Ear hole closure
One month after chimeric reconstitution, mice were ear punched bilaterally in the center of each ear pinna with a standard rodent ear punch producing a hole with a diameter of 2 mm as previously described . At 15 and 30 days the diameter of the holes was measured using a reticle.
Surgical procedures
Myocardial injury was produced cryogenically, trans-diaphragmatically, as previously reported (Leferovich et al., 2001) , without puncturing the diaphragm muscle, on the right ventricular surface of the heart as follows: a 6-8-mm incision was made through the skin on the ventral surface of the abdomen below the ribcage approximately 5 mm caudal to the sternum and 5 mm to the left of the midline. The underlying musculature has been incised similarly. The diaphragm was exposed using forceps to retract the medial lobe of the liver and the overlying musculature. The right ventricular surface of the heart is thus presented directly adjacent to, and clearly visible through, the diaphragm. Injury to the heart is accomplished by holding a 2 mm blunt probe, cooled in liquid nitrogen, in direct contact with the diaphragm. A ten-second exposure, followed by a second ten-second exposure, was sufficient to produce an extensive yet sublethal lesion.
Histology and immunohistochemistry
Hearts were removed, fixed overnight in Prefer (Anatech, Ltd.), and embedded in paraffin. Sections cut to a thickness of 5 microns were stained with either Masson's trichrome or hematoxylin (Surgipath cat. no. C.I. 75290) and eosin (Surgipath cat. no. C.I. 45380) with 5-and 1-min exposures, respectively.
For immunohistological staining, the following affinity purified goat antibodies were used: antihuman MEF-2C peptide (Santa Cruz, sc-13268), and anti-human Nkx 2.5 peptide (Santa Cruz Biotechnology, Inc., sc-8697). Purified anti-troponin T mab 13-11 (LabVision/Neo Markers, Fremont, CA) was also used. To block nonspecific binding, the slides were incubated for 1 h in 4% bovine serum albumin in 1 ϫ PBS for the troponin T antibody staining and in 2% normal donkey serum in 0.1 M Tris buffer for MEF-2C and Nkx-2.5 antibody staining. The slides were incubated in primary antibody overnight at 4°C using a 1:500 dilution of troponin T-specific antibody and a 1:50 dilution of antibodies specific for MEF-2C and Nkx-2.5. Binding of anti-troponin T antibody was detected by Alexa Fluor 594-labeled goat anti-mouse antibody (1:400, Molecular Probe) and binding of anti-MEF-2C and Nkx-2.5 antibodies with donkey anti-goat FITCconjugated antibody (1:200, Jackson Immunoresearch Laboratories,West Grove, PA). Nuclei were counterstained with DAPI and slides were coverslipped using Fluoromount-G (Southern Biotechnology).
Picro-sirius Red (PSR) staining and analysis
Prefer-fixed, paraffin-embedded, 7-micronthick sections of heart were stained for 3 h in Picro-sirius Red (Poly Scientific cat. no. s2365) washed 3ϫ in H 2 O and mounted. Detection of signal was carried out using polarized light and scar tissue was seen as bright orange, red, white, and blue collagen fibers on a dark background (Weber et al., 1990; Mukherjee et al., 2004; Iohara et al., 2004) . Briefly, the sites of injury of the PSRstained myocardial sections were imaged under 10ϫ magnification, illuminated by polarized light, and the resultant birefringence signals digitized using the same settings for all images. The image was then converted to grayscale. The area of extracellular staining was computed from 5-40 random and non-overlapping fields and the mean calculated using Image Pro-Plus (Media Cybernetics, Inc., Silver Spring, MD).
In-situ hybridization
A pBluescript II plasmid containing a Y chromosome DNA insert was generously provided by E. Mezey (Mezey et al., 2000) and in situ hybridization was carried out by using a digoxigenin-labeled (DIG high-prime DNA labeling kit; Roche Diagnostics) DNA probe complementary to the satellite region of the human Y chromosome. Specifically, PCR amplification produced a Y chromosome probe using the above plasmid DNA as the template and the following primer set: 5Ј TCTTAAGGTCTTGCCTCACAA-AG-3Ј and 5Ј-CATATCTCCAATTCCTTGCTC-AC-3Ј. This created an 800 bp DIG-labeled mouse Y chromosome fragment (approximately 40 DIG hapten determinants/molecule of probe). Ten-micron heart sections were prepared from Prefer-fixed, paraffin-embedded tissue blocks. After de-paraffinization and dehydration, sections were treated by autoclave boiling for 20 min in 10 mM sodium citrate buffer (pH 6.0) for future antigen retrieval and antibody reactions. DNA denaturation of tissue was performed at 100°C for 15 min and of Dig DNA probe at 95°C for 2 min. Overnight hybridization was carried out at 42°C and was followed by washing with three different concentrations of SSC (2 ϫ SSC, 1 ϫ SSC and 0.5 ϫ SSC). Each wash was carried out at 42°C for 40 min. Detection of probe hybridization was carried out using alkaline phosphatase (AP)-conjugated sheep anti-digoxigenin Fab fragments (1:100, Roche Diagnostics) and then color precipitation using nitroblue tetrazolium/5 bromo-4 chloro-3 indolyl-phosphate (NBT/BCIP; Roche Biochemicals). After in situ hybridization was complete, immunohistochemistry on the same sections for troponin T, MEF-2C, and Nkx-2.5 was performed.
RESULTS
Healer into nonhealer chimeras
Fetal liver chimeric mice were generated by lethal irradiation (9 Gy) of the recipient and then reconstitution with a single cell suspension from day e16.5 fetal liver. One to 1.5 months later, reconstituted animals were wounded by two methods, ear punching and heart cryoinjury and examined 30 days after injury.
In the first group of mice, MRL (healer) fetal liver cells (2 ϫ 10 7 /recipient) were injected into B6 (nonhealer) recipients. The degree of reconstitution was determined by the H-2K haplotype of the splenocyte populations at the time of sacrifice. The healer into nonhealer chimeric mice showed 60-80% chimerism (Fig. 1, Table 1 ).
Cryo-injury to the right ventricle of the heart showed a healer phenotype in these B6 recipients of MRL donor cells in all mice examined indicating a positive role for MRL fetal liver. This was seen in cross-sections of heart in which trichrome staining showed normal architecture similar to what is usually seen in MRL injured mice (Leferovich et al., 2001 ; Fig. 2A,C) . Furthermore, islands of cells which were not as darkly stained red as the pre-existing myocardium appeared, suggesting the development of new myocardium at the injury site (Fig. 2B,D, white arrows) .
Specific immunohistochemical staining of the injured sections showed the presence of cardiac markers in what appeared to be nascent muscle Chimerism was determined approximately 2 months post-reconstitution. MRL/MpJ mice are of the H-2Kk haplotype, and C57BL/6 mice are of the H-2Kb haplotype.
FIG. 2.
Trichrome staining of heart sections. Light micrographs of trichrome-stained, transversely sectioned cryoinfarcted hearts. The first set of 30-day injuries show MRL fetal liver into B6 chimeras (A-D) at 4ϫ magnification (A,C) and the associated region at 40ϫ magnification (B,D). The second set of 30-day injuries show B6 fetal liver into MRL chimeras (E-J) at 4ϫ magnification (E,H) and the associated regions at 10ϫ (F) and 40ϫ (G,I,J). White arrows show regions of developing islands of cardiomyocytes (B,D), and yellow arrows show myocardium-scar boundaries with no new cardiomyocyte development (G,I,J).
FIG. 3.
Immunohistochemistry of injured hearts. Heart sections from cryoinjured MRL FL into B6 chimeras were stained with anti-cardiac troponin T, anti-MEF-2C, and anti-Nkx2.5. Y chromosome in situ hybridization was detected using anti-DIG antibody and substrate precipitation. Co-staining of troponin T, Y-anti-DIG, and DAPI staining can be seen in the same section using fluorescence (A) as well as a grayscale image (B) and the original in situ results (C), which were converted to green dots in A and B. This same area is also shown using serial sections stained with MEF-2C (D), Nkx2.5 (E), and trichrome (F). All pictures are at 100ϫ magnification. Also, MEF-2C and Nkx2.5 was FITC stained and have been converted to grayscale. (Fig. 3F) . Cardiac troponin T showed positive staining though no mature Zband patterning in these fibers (Fig. 3A,B , yellow arrows). Furthermore, Y chromosome in situ hybridization showed that many of these fibers were associated with Y-positive DAPI-stained nuclei and also showed that these fibers had a single nucleus. (Fig. 3A-C) . These "neocardiomyocytes" stained positively with MEF-2C and Nkx2.5 (Fig. 3D,E) .
Unlike the heart cryoinjury, analysis of ear hole punching in these same mice showed B6 nonhealing or host dominance with the hole not closing. That the processes involved in chimera production (host x-irradiation and reconstitution) were not the cause of the lack of healing in these mice is demonstrated by the healing seen in the MRL into MRL syngeneic chimeras and the nonhealing seen in the B6 into B6 syngeneic chimeras (Table 2) .
Nonhealer into healer chimeras
In the second group of animals, chimeras were generated by injecting B6 fetal liver cells (2 ϫ 10 6 /recipient) into irradiated (9 Gy) MRL recipients. In these animals, 10-fold lower numbers of fetal liver cells were injected due to lower cell recovery from B6 fetal livers and the degree of chimerism achieved was also much lower, with an average of 12% H-2Kb or B6-derived cells. Thus, the majority of cells in these mice were MRL. It was therefore surprising that most of these mice showed a B6-type heart healing response. This was defined by a large degree of acellular scarring, irregular architecture, and few islands of new cardiomocytes even at the myocardium-scar border (Fig. 2E-J, yellow arrows) .
In these mice, again, the ear healing response was of the recipient phenotype. indicating as in the previous set of chimeras that the phenotype was dependent on a radio-resistant host cell type. Thus, the ear holes closed like the MRL (Table 2) .
Differences in collagen staining
One of the major differences between the MRL and B6 healing is the scar response. We attempted to quantitatively measure this response in these chimeras and used picro-sirius red (PSR) staining to measure the degree of collagen crosslinking at the injury site (Weber et al., 1990; Mukherjee et al., 2004; Iohara et al., 2004) .
As can be seen in Figure 4 , the normal B6 PSR response was approximately 4ϫ higher than the normal MRL response. The allogeneic chimeras showed even greater differences. However, in this case, the response was a reflection of the donor cell-type with the allogeneic MRL into B6 chimeras displaying an MRL-like collagen response and the allogeneic B6 into MRL chimeras displaying a B6-like collagen response.
DISCUSSION
Chimeras and phenotype change
These studies have demonstrated that fetal liver cells from two mouse strains with different healing phenotypes can transfer their associated healing phenotype to the recipient strain. This was shown using the MRL healer and B6 nonhealer mouse strains and employed a cryoinjury (male/female) 1.14 Ϯ 0.24 615 MRL FL into C57BL/6 (mixed/female) 1.3 Ϯ 0.33 620 C57BL/6 FL into MRL (mixed/female) 0.5 Ϯ 0.3 a Hole size at 30 days was determined to be healer-like with a value of 0-0.5 mm and to be non-healer-like with a value of 0.9-1.6 mm as previously shown McBrearty et al, 1998) .
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b Results obtained from bone marrow syngeneic chimeras (Leferovich et al., in preparation) . 
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to the right ventricle of the heart (Leferovich et al., 2001 ). The healing response was evaluated for the presence of islands of new cardiomyocytes at the injury site, for their expression of cardiac markers including the filament protein cardiac troponin T (Malouf et al., 1992) , the homeobox protein Nkx2.5 (Harvey, 1996) , and the transcription factor MEF-2C (Naya et al., 1999) and also for the presence of crosslinked collagen and acellular scar. In addition, the contribution of donor cells was determined by Y-chromosome in situ hybridization. The first set of experiments showed that fetal liver cells from healer MRL mice do convert a nonhealer B6 mouse into a mouse showing the regeneration of new cardiomyocytes. A high degree of chimerism was achieved with up to 80% of the splenocytes being derived from the MRL. The highlights of this response are the presence of new islands of cardiomyocytes and a lack of scarring. These new islands of cells appeared to stain weakly red or pink for muscle with Massons trichrome and were identified using cardiac troponin T, Nkx2.5, and MEF-2C antibodies. These islands were lacking Z-bands also indicating immature myocyte fibers.
If these are in fact immature myocyte fibers, what is the contribution of the donor cells? Many of these fibers are Y-positive, proving that in these cases they are of donor origin. Since fetal mice cannot be sexed by observation, only an unknown fraction of donor cells are male and hence have the Y chromosome. Thus, Y in situ staining underestimates donor-origin cardiomyocytes. Furthermore, it appears that there is only one nucleus per fiber in many cases suggesting transdifferentiation and not fusion.
As discussed below, the issue of scarring may be critical to the regeneration process. A lack of scarring was evident in the B6 recipient as shown by picro-sirius red, a stain for the degree of collagen crosslinking and thus scarring. On the other hand, scarring in the MRL recipient was the predominant response. It might have been expected that the poor chimerism achieved in this B6 into MRL experiment would result in a recipient-type (MRL) response. The fact that so few donor (B6) fetal liver cells could convert the phenotype indicates a powerful dominant negative-type response for regeneration. It could be that the ability to scar blocks healing. We do not know which cell population is responsible for this effect and it may be different than the population that allows for a regenerative response in the reciprocal chimeras.
Organ specificity
The transfer of phenotype in the chimeras did not apply to ear hole closure which remained unclosed in B6 recipients and healed in the MRL recipients. This result is consistent with a previous mouse ear hole closure study (Kench et al., 1999) in which nonhealer B10.BR bone marrow into healer MRL recipient chimeras and healer MRL bone marrow into nonhealer B10.BR recipient chimeras displayed the healing phenotype of the recipient, leading the authors to conclude that healing was due to a non-hematopoietic, radioresistant cell type of the host.
Cells in fetal liver
Previous studies carried out using bone marrow radiation chimeras suggested that a heart healing phenotype change does not occur using these strains (Leferovich et al., manuscript in preparation; Heber-Katz et al., 2004c) . Thus, it was surprising to find that fetal liver reconstitution could lead to this change.
What cells in the fetal liver are responsible for the transfer of this healing? We know that fetal liver has a transitory population of stem cells, the hematopoetic stem cells (HSC). There is evidence that side population cells found in the bone marrow which have HSC markers can become skeletal and cardiac muscle Gussoni et al., 1999) . Fetal liver cells which are c-kit ϩ and assumed to be HSC, when injected into an infarcted region of the mouse heart, have been shown to become cardiomyocytes (Lanza et al., 2004) . On the other hand, there are recent studies showing no cardiomyocyte regeneration by ckitϩ HSC Balsam et al., 2004) . Of course, c-kit is not only present on HSC but also on non-HSC populations such as oval cells in the liver and may be responsible for the difference in such studies (Zheng and Taniguchi, 2003) . It should also be noted that in the experiments presented here, any donor origin cells in the heart must have migrated via the circulation similar to what was described by Orlic et al. (2001b) as opposed to the mechanical transfer of cells to the injury site in the heart.
The major non-hematopoetic stem cell population in the fetal liver is the hepatoblast which is a bipotential self-renewing stem cell that can differentiate into both hepatocytes and cholangiocytes (bile duct epithelial cells). The hepatoblasts are similar to oval cells found in adult liver which appear after injury. There are several studies showing that these non-hematopoetic liver stem cells transdifferentiate into cardiomyocytes. The studies by Malouf et al. using an adult liver stem cell line dramatically demonstrates that these cells transdifferentiate both in vivo and in vitro into cardiomyocytes (Malouf et al., 2001; MullerBorer et al., 2004) . The hepatoblast population may be the cell type responsible for the transfer of phenotype in the current experiments, especially the healer phenotype transfer with the appearance of new cardiomyocytes.
Scarring
Scar formation seen in the transfer of nonhealer cells may be due to a second mechanism or population. In this case, the number of donor cells given was much lower with the degree of donor chimerism much lower as well. In the context of a healer environment, the nonhealer cells seem to affect their environment through scar formation in a dominant fashion. The results dramatically show this using picro-sirius red staining and are similar to what we had shown in injured MRL and B6 hearts using hydroxyproline levels (Leferovich et al., 2001) . Perhaps, this is accomplished by a hematopoetic stem cell which produces scarinducing factors. Our previous findings, that the regulation of proteases produced by inflammatory cells are different between MRL and B6 and play a role in the regenerative response, would suggest this (Gourevitch et al., 2003) . And, other studies from our laboratory demonstrate an effect of scar in another model system, that of spinal cord injury and recovery (Seitz et al., 2002) .
